News
A clinical trial at MSK found that music therapy for cancer-related anxiety is as effective as cognitive behavioral therapy and produces long-lasting benefits. Dr. Kevin Liou presented the results of ...
AstraZeneca and Daiichi Sankyo’s drug extended survival by 30% compared to a widely used regimen, further establishing its ...
SHA-registered beneficiaries will now have full coverage for treatment cycles costing up to Sh700,000 annually.
Sara M. Tolaney, MD, MPH, highlights a transformative year for breast cancer research at this year’s ASCO Annual Meeting.
Mwende was diagnosed with stage 0 breast cancer during a routine check-up. She had no family history, no warning signs. She ...
Adding Enhertu to Perjeta improved time without cancer growth versus standard care in advanced HER2-positive breast cancer, ...
The large molecule drug substance CDMO market is anticipated to expand at a CAGR of ~9% during the forecast period. Key ...
7d
SurvivorNet on MSNAn Exciting Option For Difficult-To-Treat HER2+ Gastric Cancer: What New Data Means For PatientsFor the first time, a medicine aimed directly at the HER2 protein improved overall survival after gastric cancer progressed ...
9d
SurvivorNet on MSNThe DESTINY Trial: New Drug Combo Can Keep HER2-Positive Metastatic Breast Cancer Under Control For LongerPositive new data suggests that more people facing advanced breast cancer may be able to put off treatment with harsh ...
Side effects from Herceptin usually improve over time ... antigen Trop-2 and inhibits DNA replication and stimulates cell death. In some cases, the targeted therapy Avastin (bevacizumab) may be ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results